Abstract
Two scientists who played leading roles in the conquest of poliomyelitis died recently. In 1954, Jonas Salk provided the first licensed polio vaccine, the formalin (and heat)-inactivated virus. Albert Sabin gave us the attenuated live virus vaccine, which was licensed in 1962. This paper takes the reader through the history of the disease, including its pathogenesis, epidemiology, vaccines, and future directions. The emphasis is on vaccines, for it seems that with proper vaccination the number of new cases is falling dramatically. It is hoped that by the year 2000, we will accomplish the goal of the World Health Organization of "a world without polio." Then, because there is no animal reservoir, we can seriously discuss when and how to eliminate the need for vaccination and ultimately destroy our stocks of poliovirus.
Full Text
The Full Text of this article is available as a PDF (238.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe S., Ota Y., Koike S., Kurata T., Horie H., Nomura T., Hashizume S., Nomoto A. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology. 1995 Feb 1;206(2):1075–1083. doi: 10.1006/viro.1995.1030. [DOI] [PubMed] [Google Scholar]
- Burke K. L., Almond J. W., Evans D. J. Antigen chimeras of poliovirus. Prog Med Virol. 1991;38:56–68. [PubMed] [Google Scholar]
- Furione M., Guillot S., Otelea D., Balanant J., Candrea A., Crainic R. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology. 1993 Sep;196(1):199–208. doi: 10.1006/viro.1993.1468. [DOI] [PubMed] [Google Scholar]
- Goldblum N., Gerichter C. B., Tulchinsky T. H., Melnick J. L. Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area. Bull World Health Organ. 1994;72(5):783–796. [PMC free article] [PubMed] [Google Scholar]
- KOPROWSKI H., JERVIS G. A., NORTON T. W. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg. 1952 Jan;55(1):108–124. doi: 10.1093/oxfordjournals.aje.a119499. [DOI] [PubMed] [Google Scholar]
- Lasch E. E., Abed Y., Abdulla K., El Tibbi A. G., Marcus O., El Massri M., Handscher R., Gerichter C. B., Melnick J. L. Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S467–S470. doi: 10.1093/clinids/6.supplement_2.s467. [DOI] [PubMed] [Google Scholar]
- MELNICK J. L. Problems associated with the use of live poliovirus vaccine. Am J Public Health Nations Health. 1960 Jul;50:1013–1031. doi: 10.2105/ajph.50.7.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melnick J. L., Proctor R. O., Ocampo A. R., Diwan A. R., Ben-Porath E. Free and bound virus in serum after administration of oral poliovirus vaccine. Am J Epidemiol. 1966 Sep;84(2):329–342. doi: 10.1093/oxfordjournals.aje.a120646. [DOI] [PubMed] [Google Scholar]
- Metcalf T. G., Melnick J. L., Estes M. K. Environmental virology: from detection of virus in sewage and water by isolation to identification by molecular biology--a trip of over 50 years. Annu Rev Microbiol. 1995;49:461–487. doi: 10.1146/annurev.mi.49.100195.002333. [DOI] [PubMed] [Google Scholar]
- NOLAN J. P., WILMER B. H., MELNICK J. L. Poliomyelitis: its highly invasive nature and narrow stream of infection in a community of high socioeconomic level. N Engl J Med. 1955 Dec 1;253(22):945–954. doi: 10.1056/NEJM195512012532201. [DOI] [PubMed] [Google Scholar]
- Ogra P. L., Faden H. S., Abraham R., Duffy L. C., Sun M., Minor P. D. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis. 1991 Jul;164(1):191–194. doi: 10.1093/infdis/164.1.191. [DOI] [PubMed] [Google Scholar]
- PAUL J. R., RIORDAN J. T., MELNICK J. L. Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos. Am J Hyg. 1951 Sep;54(2):275–285. doi: 10.1093/oxfordjournals.aje.a119485. [DOI] [PubMed] [Google Scholar]
- Ren R., Racaniello V. R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol. 1992 Jan;66(1):296–304. doi: 10.1128/jvi.66.1.296-304.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rezapkin G. V., Chumakov K. M., Lu Z., Ran Y., Dragunsky E. M., Levenbook I. S. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology. 1994 Jul;202(1):370–378. doi: 10.1006/viro.1994.1353. [DOI] [PubMed] [Google Scholar]
- Rezapkin G. V., Norwood L. P., Taffs R. E., Dragunsky E. M., Levenbook I. S., Chumakov K. M. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology. 1995 Aug 20;211(2):377–384. doi: 10.1006/viro.1995.1420. [DOI] [PubMed] [Google Scholar]
- SABIN A. B., HENNESSEN W. A., WINSSER J. Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types. J Exp Med. 1954 Jun 1;99(6):551–576. doi: 10.1084/jem.99.6.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabin A. B. Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis. 1981 May-Jun;3(3):543–564. doi: 10.1093/clinids/3.3.543. [DOI] [PubMed] [Google Scholar]
- Ward R., Melnick J. L., Horstmann D. M. POLIOMYELITIS VIRUS IN FLY-CONTAMINATED FOOD COLLECTED AT AN EPIDEMIC. Science. 1945 May 11;101(2628):491–493. doi: 10.1126/science.101.2628.491. [DOI] [PubMed] [Google Scholar]
- von Magnus H., Petersen I. Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S471–S474. doi: 10.1093/clinids/6.supplement_2.s471. [DOI] [PubMed] [Google Scholar]